Skip to main content

Table 1 Characteristics of the 94 patients

From: Analysis of the factors motivating HCV-infected patients to accept interferon therapy

Characteristics n %
Sex male / female 36/58  
Age (mean ± SD), years 57.01 ± 11.55  
Age groups 20-29 years 3 3.19%
30-39 years 5 5.32%
40-49 years 15 15.96%
50-59 years 22 23.40%
60-69 years 38 40.43%
70-79 years 11 11.70%
Employment unemployed 42 44.68%
employed 52 55.32%
Diagnosis of liver disease AH-C 1 1.06%
CH-C (after HCC treatment) 87 (5) 92.55%
LC-C (after HCC treatment) 6 (4) 6.38%
IFN therapy IFN beta monotherapy 1 1.06%
IFN beta induction therapy followed Peg-IFN alpha 2b/RBV 12 12.77%
Peg-IFN alpha 2b/RBV 60 63.83%
Peg-IFN alpha 2a/RBV 11 11.70%
Peg-IFN alpha 2a monotherapy 7 7.45%
Peg-IFN alpha 2b/RBV → Peg-IFN alpha 2a monotherapy 2 2.13%
  Peg-IFN alpha 2b/RBV → Peg-IFN alpha 2a monotherapy → Peg-IFN alpha 2a/RBV 1 1.06%
  1. SD, standard deviation; AH-C, acute hepatitis C; CH-C, chronic hepatitis C; LC-C, liver cirrhosis type C; HCC, hepatocellular carcinoma; IFN, interferon; Peg-IFN, pegylated interfeon; RBV, ribavirin.